September
26
  2:55:02 AM

Screening leads to unnecessary abortions, says Israeli study

With fresh discoveries of disease genes announced almost weekly, more and more doctors are offering parents the possibility of having an abortion to prevent affected children from being born. However, an article in the Journal of the American Medical Association questions whether screening is appropriate for treatable or non-fatal diseases. Researchers in Israel who studied Gaucher disease, a condition whose symptoms range from severe to unnoticeable, found that 25% of couples aborted babies with the bad gene even though the abnormality would not have resulted in a serious health problem.

"Not until clinicians and researchers better understand the factors that determine whether a patient... will develop severe disease or none at all will screening for Gaucher disease become useful," said Dr Ernest Beutler, an expert on the condition. Until then, he said, such screening "will likely do more harm than good."

And ethicist Dr Lainie Friedman Ross, of the University of Chicago, said that the purpose of screening was not to test for minor diseases. "We want testing to help us diagnose a serious disease, to find the right treatments for those diseases -- treatments we'll respond to -- and some want it for making decisions about serious genetic abnormalities in their potential children," she said. "Gaucher doesn't fit into any of those models."


 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Indian surrogate for US woman dies in Gurjarat
18 May 2012
Do reproductive rights survive gender reassignment?
19 May 2012
South African activists begin euthanasia campaign
19 May 2012
70 assisted suicides in Washington state in 2011
19 May 2012
Would-be grandparents pay for their daughters’ egg freezing
19 May 2012

 Tags
surrogacy, China, stem cells, sex selection, informed consent, law, research, abortion, sperm donation, Netherlands, bioethics, euthanasia, embryonic stem cells, organ trafficking, organ transplants, assisted suicide, human drama, suicide, commercialization, India, Canada, clinical trials, organ donation, neuroscience, Australia, UK, IVF, US, Down syndrome, genetic testing,